ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance

Why did the S&P 500 erase all 2025 losses? How will GOP tax bill affect Tesla and Musk? What caused UnitedHealth CEO to resign unexpectedly? How will NJ Transit strike impact commuters and businesses? Why did Coinbase shares soar after S&P inclusion? What are the implications of Nvidia’s Saudi AI deal? How are tariffs impacting Japanese automakers like Nissan and Honda? Why did Microsoft announce significant global workforce layoffs? How will Trump’s executive order affect U.S. drug prices?

ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance

benzinga.com/general/biotech/25/05/45393691/clearpoint-neuro-reports-q1-earnings-revenue-beat-eps-miss-company-affirms-fy25-guidance

ClearPoint Neuro Inc (NASDAQ:CLPT) reported first-quarter financial results after the market close on Tuesday. Here’s a rundown of the report.
Q1 Earnings: ClearPoint Neuro, a device, cell and gene therapy-enabling company, reported first-quarter revenue of $8.4 million, beating analyst…

This story appeared on benzinga.com, 2025-05-13 21:30:26.